Salesforce.com picks up a rare Wall Street downgrade, as other analysts wonder if the cloud-based customer-relationship-management company is biting off more than it can chew.
The veteran immunologist told a livestream: ‘Once we get there, we can crush this outbreak just the way we did with smallpox, with polio and with measles. So we can do it.’
Dyal Capital Partners is in talks to merge with Owl Rock Capital Partners LP, part of a complicated deal with a special-purpose acquisition company that would value the fast-growing asset managers at about $13 billion combined and take them public, according to people familiar with the matter.
The Democratic-run House of Representatives on Wednesday OKs a bill that could bar many Chinese companies from listing shares on U.S. exchanges or otherwise raising money from American investors.
Okta Inc. shares rose sharply in the extended session Wednesday after the provider of enterprise identity-management systems reported revenue and adjusted earnings that handily beat analysts’ estimates.
The U.K. government granted emergency use authorization to the COVID-19 vaccine being developed by Pfizer Inc. and German partner BioNTech SE with some fanfare on Wednesday, but experts cautioned that the news does not mean the pandemic is close to being over.
Salesforce.com Inc. shares fall after picking up the rare Wall Street downgrade, and as other analysts wonder if the cloud-based customer-relationship management company is biting off more than it can chew.
Care home residents and people over the age of 80 will be among the first to receive the Pfizer-BioNTech COVID-19 vaccine, when the U.K. rollout starts next week.
The U.K. has approved the COVID-19 vaccine from Pfizer and BioNTech, paving the way for vaccinations to begin weeks ahead of much of the rest of the world.
With a $27.7 billion deal to buy Slack Technologies Inc. — its biggest acquisition yet — Salesforce.com Inc. is poised to become an even bigger threat to Microsoft Corp. in the world of corporate software. But it could be its toughest merger yet.
While the Democratic-run House is expected this week to pass a bill that would decriminalize marijuana at the federal level, some analysts say that for the next Congress the odds of cannabis legislation becoming law stand at less than 25%.